Lead Partner: Crown Bioscience

Crown Bioscience is a cutting edge translational technology company providing drug discovery and preclinical development services in the areas of oncology, immunology, inflammation, cardiovascular, and metabolic disease. We bring clarity to drug discovery and enable clients around the world to deliver superior clinical candidates. Our premier translational platforms for cancer, inflammation, and metabolic disease help our clients accelerate their new drug development programs.


Expertise Partner: Study Log

Studylog’s Animal Study Workflow Software® is designed for biomedical animal research and provides features for the design, planning, execution, analysis, and reporting of animal studies in a standardized, highly efficient manner, while protecting data integrity. Reducing many labs’ study-related labour by half, Studylog automates and streamlines the entire animal study process, making it easier, faster and cheaper, so researchers have more time and resources to get their job done.

genOway Logo

Programme Partner: Genoway

For the past 20 years, genOway has aimed to improve the predictability and reliability of preclinical data by designing models of high physiological relevancy to best meet researchers’ needs. With a catalog of humanized immune checkpoint mouse models, and mice featuring the human immune system, genOway possesses a broad set of tools to help decipher the mechanism of action as well as the efficacy and safety of drugs targeting the immune system. Additionally, genOway owns strong intellectual property rights, combining patents and licensing agreements, enabling the company to provide end users the necessary freedom to operate.


Program Partner: INOVOTION

INOVOTION is a Contract Research Laboratory implementing a unique approach to In Vivo evaluation for anti-cancer drug discovery. Our cutting-edge proprietary technology provides early analysis of your compounds before the classical preclinical stage. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process and significantly reduces its costs. INOVOTION has developed a unique technology dedicated to early In Vivo EFFICACY and TOXICITY evaluation of anticancer drugs.


Spotlight Partner: Labcorp

Labcorp is a leading global life sciences company that provides vital information
to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve live.

Learn more about and Labcorp at or follow us on LinkedIn and Twitter @Labcorp

Reaction Biology_original_jpg

Spotlight Partner: Reaction Biology Europe 

Reaction Biology Europe is a leading contract research organization for discovery of conventional and immune-modulating drugs in oncology. As an innovation driver in the area of immuno- oncology, we will introduce SubQPerior, an implantation method to overcome common issues such as heterogeneity and ulceration in subcutaneous tumor models. We have partnered with Reaction Biology, an early-stage drug discovery CRO, to provide our customers with a full suite of services for targeted and phenotypic drug discovery approaches. Let’s discover together.

Champions Oncology

Exhibition Partner: Champions Oncology

Champions Oncology was founded by renowned specialists in the field of cancer diagnosis, treatment, and research. The Champions Oncology team is comprised of seasoned oncology professionals passionately dedicated to working to accelerate oncology drug development, improve treatment outcomes and extend lives. Champions Personalized TumorGrafts™ empower patients and physicians using an in vivo xenograft mouse avatarbased diagnostic model that has shown to be predictive of a patients’ clinical response.



Repositive is a technology company with the mission to increase discovery, access and sharing of genomic data for the benefit of patients. In 2017 we initiated a collaboration with leading biopharma organisations and CROs to launch the Cancer Models Platform to act as a market place of translational oncology models and a network for oncology researchers. The platform incorporates PDX, CDX, syngeneic and humanised mouse models, 3D in vitro systems and other popular translational cancer models. Our vision is becoming the largest catalogue of commercially

vivo pharm

Exhibition Partner: vivoPharm

VIVOPHARM, a CGI company (NASDAQ:CGIX), is a successful and fast-growing precision contract research organisation (CRO) providing integrated preclinical services from bench to bedside worldwide. We use our experience and expertise to assist in the planning of and conducting tailored studies, from discovery stages through to clinical.